Hematological Cancer

2

Review clinical trials related to Hematological Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers

This study will be conducted in a randomized controlled experimental design to examine The effect of art-based intervention on fatigue, anxiety, perception of nurse presence, and quality of life in patients with hematological cancer. The study will be conducted with 52 patients (26 intervention, 26 control groups) treated in the Hematology department of a training and research hospital between May 2025 and October 2026. Art-based intervention will be applied to the intervention group for 2 week (3 sessions per week), No application will be made to the control group. The data collection tools in the study are the Patient Identifier Information Form, Cancer Fatigue Scale, Functional Assessment of Cancer Therapy-General Scale (FACT-G), Hospital Anxiety and Depression Scale (HADS), and Nurse Presence Scale (PONS).

Participants needed: 52
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Gazi UniversityUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Being between 18 and 65 years of age [+6]

Having vision loss and hearing loss, [+3]

Status: Recruiting

Parental Support Intervention in an Advanced Oncological Context

This prospective, two-arm randomized trial compares a psycho-educational program to a psycho-educational and experiential program for parents with advanced cancer. These two interventions aim to support parent-child communication about cancer, but we hypothesize that the combined intervention will be more effective for all studied communication variables.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Université Libre de BruxellesUpdated: Jan 14, 2026Locations: 1
Eligibility criteria

Metastatic cancer, recurrence of cancer or certain types of hematological cancer... [+4]

Severe neurological disorder [+2]